# OnCo record nct04395508 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04395508/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04395508", "NCT04395508" ;
  schema:name "At-home pertuzumab and trastuzumab expanded access"@en ;
  schema:alternateName "An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic"@en ;
  schema:description "This expanded-access program provided at-home injections of pertuzumab and trastuzumab to support continuity of care during the pandemic. It is not a randomized trial; the registry now marks the program approved for marketing."@en ;
  schema:url <https://onco.cc/trials/nct04395508/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04395508>, <https://clinicaltrials.ucsf.edu/trial/NCT04395508> ;
  onco:tag "ucsf-breast-coverage", "expanded-access" ;
  onco:phase "not-applicable" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/pertuzumab/>, <https://onco.cc/drugs/trastuzumab/> ;
  onco:institutions <https://onco.cc/institutions/ucsf/> .